Compositions And Methods Of Using Crmp-1 And Its Fragments For Treating Cancer


The present invention discloses a method for treating cancer by using hCRMPI and/or active fragments thereof, as well as the active fragments of hCRMPI that are capable of inhibiting cell proliferation, invasive activity, and metastasis of cancer. The method can also be used prior to, or in combination with, the administration a chemotherapy agent. A vector capable of expressing an hCRMPI, a variant of hCRMPI, a fragment of hCRMPI or a variant of a fragment of hCRMPI is also disclosed.


Download Citation

Sign in to the Lens